OA10161A - Amine derivatives - Google Patents

Amine derivatives Download PDF

Info

Publication number
OA10161A
OA10161A OA60669A OA60669A OA10161A OA 10161 A OA10161 A OA 10161A OA 60669 A OA60669 A OA 60669A OA 60669 A OA60669 A OA 60669A OA 10161 A OA10161 A OA 10161A
Authority
OA
OAPI
Prior art keywords
phenyl
formula
compounds
methyl
oxo
Prior art date
Application number
OA60669A
Other languages
English (en)
Inventor
Duncan Robert Armour
Philip Charles Box
Pritom Shah
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of OA10161A publication Critical patent/OA10161A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA60669A 1992-12-05 1995-05-30 Amine derivatives OA10161A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929225492A GB9225492D0 (en) 1992-12-05 1992-12-05 Amine derivatives

Publications (1)

Publication Number Publication Date
OA10161A true OA10161A (en) 1996-12-18

Family

ID=10726205

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60669A OA10161A (en) 1992-12-05 1995-05-30 Amine derivatives

Country Status (29)

Country Link
US (1) US5569654A (pt)
EP (1) EP0672037B1 (pt)
JP (1) JPH08504200A (pt)
KR (1) KR950704270A (pt)
CN (1) CN1093085A (pt)
AT (1) ATE168102T1 (pt)
AU (1) AU688295B2 (pt)
BG (1) BG99696A (pt)
BR (1) BR9307580A (pt)
CA (1) CA2150461A1 (pt)
CZ (1) CZ138495A3 (pt)
DE (1) DE69319614D1 (pt)
EC (1) ECSP941085A (pt)
FI (1) FI952709A (pt)
GB (1) GB9225492D0 (pt)
HU (1) HUT71339A (pt)
IL (1) IL107869A (pt)
MX (1) MX9307654A (pt)
NO (1) NO952208L (pt)
NZ (1) NZ258874A (pt)
OA (1) OA10161A (pt)
PE (1) PE54294A1 (pt)
PL (1) PL309281A1 (pt)
RO (1) RO114446B1 (pt)
RU (1) RU95114528A (pt)
SK (1) SK74195A3 (pt)
TW (1) TW237450B (pt)
WO (1) WO1994013648A1 (pt)
ZA (1) ZA939068B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9314981D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
US5428157A (en) * 1993-11-22 1995-06-27 Merck & Co., Inc. 3-acylaminobenzodiazepines
WO1995028399A1 (en) * 1994-04-15 1995-10-26 Glaxo Wellcome Inc. A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds
US5807876A (en) * 1996-04-23 1998-09-15 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme
AUPO284396A0 (en) * 1996-10-08 1996-10-31 Fujisawa Pharmaceutical Co., Ltd. Benzodiazepine derivatives
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
NZ500353A (en) 1997-04-14 2002-02-01 Cor Therapeutics Inc Cyclic diaza compounds that are selective inhibitors of factor Xa
US6369063B1 (en) 1997-04-14 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
AU747531B2 (en) 1997-04-14 2002-05-16 Millennium Pharmaceuticals, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6333321B1 (en) * 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6100254A (en) * 1997-10-10 2000-08-08 Board Of Regents, The University Of Texas System Inhibitors of protein tyrosine kinases
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7297346B2 (en) * 2001-05-25 2007-11-20 Cephalon Inc. Pharmaceutical formulations of modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
EP1824843A2 (en) * 2004-12-07 2007-08-29 Locus Pharmaceuticals, Inc. Inhibitors of protein kinases
US7741479B2 (en) * 2004-12-07 2010-06-22 Locus Pharmaceuticals, Inc. Urea inhibitors of MAP kinases
JP2009522363A (ja) * 2006-01-04 2009-06-11 ローカス ファーマシューティカルズ、インク. プロテインキナーゼの阻害剤
GB201414116D0 (en) * 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2032226A1 (en) * 1989-12-18 1991-06-19 Mark G. Bock Benzodiazepine analogs
CA2068355A1 (en) * 1991-05-14 1992-11-15 Mark S. Chambers Benzodiazephine derivatives, compositions containing them and their use in therapy
GEP20001968B (en) * 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents

Also Published As

Publication number Publication date
BR9307580A (pt) 1999-06-29
CZ138495A3 (en) 1995-12-13
WO1994013648A1 (en) 1994-06-23
MX9307654A (es) 1994-06-30
ZA939068B (en) 1994-08-09
RO114446B1 (ro) 1999-04-30
FI952709A (fi) 1995-08-01
CA2150461A1 (en) 1994-06-23
NO952208D0 (no) 1995-06-02
RU95114528A (ru) 1997-06-10
HU9501622D0 (en) 1995-08-28
FI952709A0 (fi) 1995-06-02
GB9225492D0 (en) 1993-01-27
ATE168102T1 (de) 1998-07-15
HUT71339A (en) 1995-11-28
CN1093085A (zh) 1994-10-05
AU5694894A (en) 1994-07-04
KR950704270A (ko) 1995-11-17
IL107869A (en) 1998-10-30
BG99696A (bg) 1996-01-31
SK74195A3 (en) 1995-11-08
US5569654A (en) 1996-10-29
PL309281A1 (en) 1995-10-02
PE54294A1 (es) 1995-01-06
ECSP941085A (es) 1994-12-15
IL107869A0 (en) 1994-04-12
NZ258874A (en) 1996-09-25
DE69319614D1 (de) 1998-08-13
EP0672037B1 (en) 1998-07-08
JPH08504200A (ja) 1996-05-07
NO952208L (no) 1995-08-02
AU688295B2 (en) 1998-03-12
TW237450B (pt) 1995-01-01
EP0672037A1 (en) 1995-09-20

Similar Documents

Publication Publication Date Title
EP0672037B1 (en) 1,4-benzodiazepine derivatives and their use as cck-modulators
RU2124009C1 (ru) Производные 1,5-бензодиазепина, способ их получения, фармацевтическая композиция
DE69426624T2 (de) 1,5 benzodiazepinoderivate mit cck-antagonisierender und oder agonisierender wirkung
JP2002504484A (ja) 新規化合物
AU667690B2 (en) Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
US5302591A (en) Benzodiazepine derivatives
KR100347287B1 (ko) 콜레시스토키닌또는가스트린의길항물질로서유용한1,5-벤조디아제핀유도체
US5686449A (en) 1,5-benzodiazepines useful as gastrinor CCK-antagonists
CZ286764B6 (en) 5-Heterocyclo-1,5-benzodiazepine derivatives, process of their preparation and pharmaceutical preparation containing thereof
US5696110A (en) Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
SK125495A3 (en) 1,5-benzodiazepine derivatives, manufacturing process, their use and pharmaceutical compositions containing them
AP479A (en) Amine derivatives.
US5486514A (en) Carbamate derivatives
HRP940330A2 (en) Amine derivatives
GB2266528A (en) Benzodiazepine derivatives